JAZZ PHARMACEUTICALS PLC (JAZZ)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for JAZZ
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JAZZ | Chief Executive Officer, Theravance Biopharma, Inc.; Lead Independent Director; Member | 66 | ["Experience in senior management positions in the pharmaceuticals industry","Significant industry knowledge","Operational and management expertise","Deep knowledge of global marketing, commercialization and market access"] | ["Audit Committee","Compensation Committee","Nominating Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TBPH | Chief Executive Officer and Director | 66 | ["M.B.A. from Texas Christian University","B.S. degree from Southern Illinois University","Served as Chief Executive Officer since June 2014","Former CEO of Innoviva","Experience in oncology/hematology from Bristol Myers Squibb","Chairman of CHI and CLSA","Member of Biotechnology Industry Organization’s board"] | [] | 2026 |
| INVA | Chief Executive Officer and Director | 54 | [] | [] | 2014 |
Biography sourced from the proxy statement filing.
Rick E Winningham has served as CEO of Theravance BioPharma since its spin-off from Theravance, Inc. (now Innoviva, Inc.) in June 2014. From October 2001 to August 2014, Mr. Winningham served as CEO of Theravance, Inc., where he also served as Chairperson of the board of directors from April 2010 to October 2014. From 1997 to 2001, he served as President of Bristol-Myers Squibb Oncology/Immunology Therapeutics Network and, from 2000 to 2001, as President of Global Marketing. Mr. Winningham is a member of Biotechnology Innovation Organization s board of directors. He is also cofounder of and strategic advisor to Praxis Bioresearch. He has served as a member of the board of directors of Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, since February 2024. He previously served as a member of the board of directors of Retrotope, Inc., a private biotechnology company focused on cell degeneration, from February 2021 to January 2022 and OncoMed Pharmaceuticals, Inc. from June 2015 until the company s merger with Mereo BioPharma Group plc in April 2019. He also served as a member of the board of directors of the California Healthcare Institute from November 2011 to March 2015 and served as its Chairperson from January 2014 until the California Healthcare Institute merged with Bay Area Bioscience Association to become the California Life Sciences Association in March 2015. Mr. Winningham served on the board of directors of California Life Sciences Association from March 2015 to July 2023, and served as its Chairperson from March 2015 until November 2015. Mr. Winningham holds an M.B.A. from Texas Christian University and a B.S. from Southern Illinois University.